TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS

TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS

Conversion of the incurable disease in the chronic form and improvement of the life quality parameters on the background of appearance of new drugs is of specific importance for patients with NSCLC with activating mutations. “ESMO thinks that treatment of patients with wide-spread and incurable canc...

Full description

Bibliographic Details
Main Authors: T. Y. SEMIGLAZOVA, A. S. ZHABINA, А. V. BELYAEVA, V. A. KLUGE, K. V. USOVA, D. H. LATIPOVA, G. M. TELETAEVA, A. V. NOVIK, A. I. SEMENOVA, S. A. PROTSENKO
Format: Article
Language:Russian
Published: Remedium Group LLC 2016-12-01
Series:Медицинский совет
Subjects:
itk egfr
pfs
quality of life
nsclc mut +
afatinib
Online Access:https://www.med-sovet.pro/jour/article/view/1406
id doaj-7ac0b7e66bad4bcaa3c872a3ba8a7d62
record_format Article
spelling doaj-7ac0b7e66bad4bcaa3c872a3ba8a7d622021-07-28T13:29:24ZrusRemedium Group LLCМедицинский совет2079-701X2658-57902016-12-01010566510.21518/2079-701X-2016-10-56-651403TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTST. Y. SEMIGLAZOVA0A. S. ZHABINA1А. V. BELYAEVA2V. A. KLUGE3K. V. USOVA4D. H. LATIPOVAG. M. TELETAEVA5A. V. NOVIK6A. I. SEMENOVA7S. A. PROTSENKO8FSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of Russia; SBEI HPE Mechnikov NWMU of the Ministry of Health of RussiaFSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of Russia; SBHI Saint-Petersburg Clinical Scientific and Practical Center of Specialized Medical Aid Types (Oncologic)FSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of RussiaFSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of RussiaFSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of RussiaFSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of RussiaFSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of RussiaFSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of RussiaFSBI Petrov Oncology Scientific and Research Institute of the Ministry of Health of RussiaConversion of the incurable disease in the chronic form and improvement of the life quality parameters on the background of appearance of new drugs is of specific importance for patients with NSCLC with activating mutations. “ESMO thinks that treatment of patients with wide-spread and incurable cancer forms a greater share of the oncologists work… and for these patients the quality of life is of chief importance irrespective of its duration. Use of high-precision targeted anti- EGFR therapy allows considerably improving the quality of life of oncologic patients with non-small pulmonary carcinoma with activating mutations.https://www.med-sovet.pro/jour/article/view/1406itk egfrpfsquality of lifensclc mut +afatinib
collection DOAJ
language Russian
format Article
sources DOAJ
author T. Y. SEMIGLAZOVA
A. S. ZHABINA
А. V. BELYAEVA
V. A. KLUGE
K. V. USOVA
D. H. LATIPOVA
G. M. TELETAEVA
A. V. NOVIK
A. I. SEMENOVA
S. A. PROTSENKO
spellingShingle T. Y. SEMIGLAZOVA
A. S. ZHABINA
А. V. BELYAEVA
V. A. KLUGE
K. V. USOVA
D. H. LATIPOVA
G. M. TELETAEVA
A. V. NOVIK
A. I. SEMENOVA
S. A. PROTSENKO
TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS
Медицинский совет
itk egfr
pfs
quality of life
nsclc mut +
afatinib
author_facet T. Y. SEMIGLAZOVA
A. S. ZHABINA
А. V. BELYAEVA
V. A. KLUGE
K. V. USOVA
D. H. LATIPOVA
G. M. TELETAEVA
A. V. NOVIK
A. I. SEMENOVA
S. A. PROTSENKO
author_sort T. Y. SEMIGLAZOVA
title TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS
title_short TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS
title_full TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS
title_fullStr TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS
title_full_unstemmed TARGETED THERAPY OF NSCLC WITH EGFR ACTIVATING MUTATIONS IMPROVES THE QUALITY OF LIFE OF PATIENTS
title_sort targeted therapy of nsclc with egfr activating mutations improves the quality of life of patients
publisher Remedium Group LLC
series Медицинский совет
issn 2079-701X
2658-5790
publishDate 2016-12-01
description Conversion of the incurable disease in the chronic form and improvement of the life quality parameters on the background of appearance of new drugs is of specific importance for patients with NSCLC with activating mutations. “ESMO thinks that treatment of patients with wide-spread and incurable cancer forms a greater share of the oncologists work… and for these patients the quality of life is of chief importance irrespective of its duration. Use of high-precision targeted anti- EGFR therapy allows considerably improving the quality of life of oncologic patients with non-small pulmonary carcinoma with activating mutations.
topic itk egfr
pfs
quality of life
nsclc mut +
afatinib
url https://www.med-sovet.pro/jour/article/view/1406
work_keys_str_mv AT tysemiglazova targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT aszhabina targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT avbelyaeva targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT vakluge targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT kvusova targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT dhlatipova targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT gmteletaeva targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT avnovik targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT aisemenova targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
AT saprotsenko targetedtherapyofnsclcwithegfractivatingmutationsimprovesthequalityoflifeofpatients
_version_ 1721274370001731584

Similar Items